According to Vistin Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.76. At the end of 2024 the company had a P/S ratio of 2.35.
Year | P/S ratio | Change |
---|---|---|
2024 | 2.35 | -3.45% |
2023 | 2.44 | -1.3% |
2022 | 2.47 | -19.52% |
2021 | 3.07 | -9.68% |
2020 | 3.40 | 68.61% |
2019 | 2.01 | 29.12% |
2018 | 1.56 | 24.38% |
2017 | 1.25 | -8.53% |
2016 | 1.37 |